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Use of different RT-QuIC substrates 
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Chronic wasting disease (CWD) is a highly contagious prion disease affecting captive and free-ranging 
cervid populations. CWD has been detected in United States, Canada, South Korea and, most 
recently, in Europe (Norway, Finland and Sweden). Animals with CWD release infectious prions in 
the environment through saliva, urine and feces sustaining disease spreading between cervids but 
also potentially to other non-cervids ruminants (e.g. sheep, goats and cattle). In the light of these 
considerations and due to CWD unknown zoonotic potential, it is of utmost importance to follow 
specific surveillance programs useful to minimize disease spreading and transmission. The European 
community has already in place specific surveillance measures, but the traditional diagnostic tests 
performed on nervous or lymphoid tissues lack sensitivity. We have optimized a Real-Time Quaking-
Induced Conversion (RT-QuIC) assay for detecting CWD prions with high sensitivity and specificity to 
try to overcome this problem. In this work, we show that bank vole prion protein (PrP) is an excellent 
substrate for RT-QuIC reactions, enabling the detection of trace-amounts of CWD prions, regardless of 
prion strain and cervid species. Beside supporting the traditional diagnostic tests, this technology could 
be exploited for detecting prions in peripheral tissues from live animals, possibly even at preclinical 
stages of the disease.
Chronic Wasting Disease (CWD) is a prion disease, a neurodegenerative disorder that affects cervid populations. 
It was first identified in 1967 in a captive mule deer from Colorado. CWD was then diagnosed across a wide area 
of North America1 where it is spreading extensively. It has also been reported in South Korea, as a consequence of 
infected animals imported from Canada2 and has most recently been reported in Europe3 (Norway, Finland and 
Sweden4,5). To date, CWD has been identified in mule deer (Odocoileus hemionus)6, black-tailed deer (Odocoileus 
hemionus), white-tailed deer (Odocoileus virginianus)7, elk (Cervus canadensis)6,8 moose (Alces alces)9, reindeer 
(Rangifer tarandus tarandus) and red deer (Cervus elaphus)2,10–12.
As in other prion diseases, the causative agent is considered to be an abnormally folded isoform of the prion 
protein (PrPC), named prion or PrPSc13, which accumulates mostly in the central nervous system (CNS). PrPC 
plays important roles in several physiological processes and is evolutionarily conserved amongst different mam-
malian species3,6,14–19. Misfolded PrPSc propagates through conformational templating where PrPC is converted 
into PrPSc thus acquiring infectious features and sustaining disease13,20.
Horizontal transmission of CWD is highly efficient, through both animal-to-animal contact and exposure to 
environments contaminated with prion infected material (e.g. excreta, placenta or carcasses)21–24. Polymorphisms 
in the PrP gene (Prnp) are known to affect (i) animal susceptibility to CWD, (ii) transmission efficiency between 
species, (iii) clinical and (iv) neuropathological features of the disease25–28. For instance, deer PrPC is charac-
terized by having a glycine (G) or serine (S) at codon 96 of Prnp29,30; Moose PrPC contains either lysine (K) or 
glutamine (Q) at position 10931; Elk PrPC has either methionine (M) or leucine (L) at position 13226; Reindeer 
PrPC has aspartic acid (D) or asparagine (N) at residue 17631; Mule deer PrPC contains either serine (S) or phe-
nylalanine (F) at position 22532 while Whitetail deer is characterized by having alanine (A) or glycine (G) at 
position 116 and glutamine (Q) or lysine (K) at position 22628. These amino acids determine important variability 
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in disease phenotypes or susceptibility to CWD infection. For example, the expression of L at position 132 of elk 
PrP appears to confer, at least partially, resistance to CWD when compared to the more prevalent 132 M allele33. 
Similarly, the expression of S at position 96 of deer PrP is linked to reduced incidence of CWD34.
Thus, other than dictating CWD susceptibility, PrP polymorphisms seem to play an important role in prion 
strains selection35–37. Strains are extremely relevant in prion diseases since they determine variability in clinical 
phenotype of the disease, and influence the characteristics of PrPSc that acquires distinct biochemical proper-
ties (e.g., electrophoretic mobility in Western blot (WB) and analysis of glycoforms ratio after treatment with 
proteinase K) and differentially accumulates in specific brain areas38–43. Differences in strain behavior and fea-
tures are known to rely on different abnormal conformations that could be acquired by PrPSc. Strains conforma-
tional mutations can be further promoted during CWD transmission between species where PrPSc is subjected to 
important processes of selection and adaptation in the new host36,44–46.
Definite CWD diagnosis relies on post-mortem detection of PrPSc in the brainstem and the head lymph 
nodes47–49 using rapid tests (enzyme-linked immunosorbent assays (ELISA), WB and/or immunohistochemistry 
(IHC))50–52. PrPSc can be detected in peripheral lymphoid tissues (especially those associated with the alimentary 
canal) of most CWD affected animals, like in sheep affected with classical scrapie, before it can be detected in 
the brain48,53,54. For instance, IHC analyses of the palatine tonsils and recto-anal mucosa-associated lymphoid 
tissues (RAMALT) are used for an ante-mortem diagnosis of CWD in deer49,55–57. Nevertheless, in some CWD 
affected elks, while PrPSc is detected in the brain, the presence of PrPSc in the lymphoid tissues can be minimal or 
undetectable, which represents an important limitation for the ante-mortem diagnosis58,59. Similarly, Norwegian 
moose and red deer show PrPSc in the brain but PrPSc was not detected in lymphoid tissues3,9,60. Reindeer in 
Norway, conversely, have detectable lymphoid PrPSc accumulation even in animals where no PrPSc is detected in 
the CNS3.
However, at early stages of the disease, also the amount of PrPSc in peripheral lymph nodes is lower than the 
detection threshold of traditional diagnostic techniques61. In this case, the most reliable way to detect low titer 
of infectious prions is therefore by animal bioassay. Even though these experiments remain the gold standard 
for measuring low amounts of infectivity, they are time consuming, expensive and can therefore not be used as 
screening tests62–65.
Thanks to the recent development of in vitro cell-free amplification techniques, including the Protein 
Misfolding Cyclic Amplification (PMCA) and the Real Time Quaking Induced Conversion (RT-QuIC) assays, it 
is possible to detect trace-amounts of CWD prions in different peripheral tissues and biological fluids66. In par-
ticular, PMCA showed the presence of PrPSc in muscles67, feces68,69, saliva70, cerebrospinal fluid (CSF)71 and even 
the blood of animals at different stages of CWD infection72,73. Unfortunately, there is no universal PMCA sub-
strate for amplifying CWD from different species. This technique, therefore would seem not to be the method of 
choice when analyzing samples that are collected in the field (feces or saliva) from species with unknown origin. 
In RT-QuIC, through alternate cycles of incubation and shaking, prions force the substrate of reaction (recom-
binant PrP) to adopt β-sheet structures74. These abnormally folded PrP proteins aggregate and form amyloid 
fibrils whose growth is monitored with Thioflavin-T (ThT) fluorescent dye. The assay has been used extensively 
for detecting CWD prions in nasal swabs75, lymphoid tissues76, CSF71, blood77, saliva78,79, urine80 and feces81,82 of 
animals at clinical and, sometimes, preclinical stages of disease. The presence of CWD prions in the saliva, urine 
and feces of affected animals suggests that substantial environmental contamination can occur during the entire 
course of the disease, especially considering that sialorrhea and polyuria are common in diseased animals83–87. 
Moreover, prions can persist in the environment for many years and thus represent a serious risk of future con-
tamination upon restocking of CWD-exposed areas1,88–93.
For this reason, RT-QuIC due to its high sensitivity and high-throughput potential can have useful applica-
tions for ante-mortem identification of CWD infected animals. However, the technique detects different prion 
strains or strains belonging to different species with variable efficiency. To date, most of the RT-QuIC experiments 
described in the literature have been performed using primarily Syrian hamster or deer PrP as substrate of reac-
tion (see Table 1). In the present study, RT-QuIC analyses were performed on serial dilutions of brain homoge-
nates collected from both healthy and CWD-affected Norwegian moose, reindeer and red deer, using different 
substrates. We evaluated the ability of truncated PrP from Syrian hamster, bank vole, deer, reindeer and elk to 
detect brain derived PrPSc regardless of animal species or prion strain. This is also the first time where RT-QuIC 
has been used to analyze samples from CWD affected Norwegian reindeer.
Our results indicate that the use of bank vole PrP provided efficient prion detection in all CWD affected 
animals, even in the instances where traditional diagnostic methods (WB, IHC or ELISA) failed to demonstrate 
the presence of PrPSc. This optimized RT-QuIC assay could therefore be used as a screening test for CWD detec-
tion. It could also be a useful research tool for analyzing other tissues with low levels of PrPSc like peripheral 
tissues from live animals or excreta (such as urine, saliva and blood) that can be collected through non-invasive 
procedures. Moreover, although there are no documented cases of natural interspecies transmission of CWD to 
non-cervid animals, many livestock (especially sheep and goats) which share their habitat with diseased cervids 
will be exposed to prions and could potentially be infected. Although there is a so-called “species barrier”, which 
is related to differences in PrP sequences between donor and acceptor animals that can limit the efficiency of 
prion transmission between species (spillover phenomenon that occur for instance from cervids to small rumi-
nants), the potential risk of breaking such barrier cannot be excluded. For instance, CWD transmission to other 
species (especially human) cannot be completely ruled out at present64,94,95. For this reason, identifying preclinical 
CWD affected animals is of fundamental importance for minimizing horizontal disease transmission.
3Scientific RepoRtS |         (2019) 9:18595  | https://doi.org/10.1038/s41598-019-55078-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
Results
teSeetM WB analysis detects prions in brain or lymph nodes of CWD affected animals. The 
CWD affected animals used in this study were identified through the Norwegian surveillance program for CWD 
that has been started in 2016. These animals were firstly diagnosed by TeSeETM ELISA test and then confirmed by 
WB analysis (diagnostic statuses are summarized in Table 2). To verify the presence of different distribution pat-
terns of CWD prions in both brain and lymph nodes WB analyses were finally performed. Proteinase K resistant 
PrP (PrPres) was found in the samples from all the CWD affected moose (Mo1, Mo2 and Mo3) and red deer (Rd1), 
while PrPres was detected only in 3 out of 7 brain samples of CWD affected reindeer (Fig. 1a). In contrast, PrPres 
was not found in the lymph nodes of CWD affected moose and red deer but always detected in lymph nodes of 
the CWD affected reindeer (Re1-Re7) (Fig. 1b). PrPres was not detected in any of the samples (brain or lymph 
node) collected from healthy animals.
RT-QuIC analysis with bank vole PrP enables efficient prion detection in brain samples from 
cervids where PrPSc was biochemically detected. With the aim of evaluating the efficiency of dif-
ferent substrates in detecting CWD prions in different cervid species, RT-QuIC experiments were performed 
using recombinant PrP proteins with amino acidic sequences belonging to the following animal species: Syrian 
hamster, bank vole (109 M), deer (96 G), reindeer (176D) and elk (132 M) (Fig. 2). According to the most recent 
publications (see Table 1), we decided to use truncated proteins since the C-terminal protein domain allows prion 
detection with high sensitivity and specificity96,97. Evaluation of the overall RT-QuIC performance was based on 
brain samples collected from CWD affected animals where PrPSc was detected by means of TeSeETM ELISA and 
Species Prion Tissue analyzed Substrate Year References
Deer CWD Brain Deer PrP (24–234) 2010 130
Deer CWD Brain, urine and feces Deer PrP (24–234) 2013 80
Deer CWD Saliva Syrian hamster PrP (90–231) 2013 79
Deer CWD Blood Syrian hamster PrP (90–231) 2013 77
Deer CWD CSF Syrian hamster PrP (90–231) 2013 71
Deer CWD Retropharyngeal lymph node Syrian hamster PrP (90–231) 2014 131
Deer CWD Brain, saliva Syrian hamster PrP (90–231) 2015 132
Deer
Elk CWD Brain Bank vole (23–230) 2015
100
Deer CWD Saliva, urine Syrian hamster PrP (90–231) 2015 78
Deer CWD Brain Deer PrP (23–231) 2015 124
Deer CWD RAMALT, nasal brush Syrian hamster PrP (90–231) 2016 75
Elk CWD RAMALT, nasal brush Syrian hamster PrP (90–231) 2016 76
Deer CWD Feces Syrian hamster PrP (90–231) 2016 69
Deer CWD Brain, lymphoid tissues Syrian hamster PrP (90–231) 2017 133
Deer CWD
Ovary tissue, uterine tissue, 
placentome, amniotic and 
allantoic fluids
Syrian hamster PrP (90–231) 2017 134
Deer CWD Brain Deer PrP (24–234) 2017 135
Deer CWD
Gastrointestinal tissues (e.g. 
omasum, abomasum, colon, cecum) 
and lymphoid tissues (e.g. spleen, 
tonsils)
Syrian hamster PrP (90–231) 2017 136
Elk CWD Feces Syrian hamster PrP (90–231) 2017 82
Elk CWD RAMALT Syrian hamster PrP (90–231) 2017 137
Deer CWD Saliva Syrian hamster PrP (90–231) 2017 138
Deer
Elk CWD RAMALT
White-tailed deer PrP (25–232)
2017 139
Mule deer PrP (25–232)
Fallow deer PrP (25–232)
Elk PrP (25–232)
Reindeer PrP (25–232)
Elk CWD Blood, rectal biopsy Syrian hamster PrP (90–231) 2018 140
Deer
Elk CWD Retropharyngeal lymph node, brain Syrian hamster PrP (90–231) 2018
60
Deer CWD Saliva Syrian hamster PrP (90–231) 2018 70
Elk CWD Brain Elk PrP (23–231) 2018 141
Elk CWD Brain Syrian hamster PrP (90–231) 2019 4
Deer CWD Brain Syrian hamster PrP (90–231) 2019 142
Deer CWD Brain, eyelids Syrian hamster PrP (90–231) 2019 143
Table 1. Summary of RT-QuIC substrates (PrP) used to analyze different tissues of CWD affected cervid 
species.
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WB. Brain homogenates of Rd1, Mo1, Mo2, Mo3, Re1, Re2 and Re3 were diluted from 10−5 to 10−7 and subjected 
to RT-QuIC analysis. Brain samples of healthy animals (Rd2, Rd3, Mo4, Mo5, Re8 and Re9) were used as controls.
Regardless of the animal species or brain dilution, bank vole PrP enabled PrPSc detection with a higher sen-
sitivity and specificity compared to the other tested substrates (Fig. 3a). Particularly, all CWD affected animals’ 
samples induced RT-QuIC seeding activity within 10 hours while those of healthy controls did not. The reaction 
was stopped at 16 hours because at this point negative controls started to induce unspecific seeding activity.
Compared to the bank vole PrP, Syrian hamster PrP substrate did not detect all CWD affected animals’ sam-
ples and the sensitivity decreased at higher dilutions. In particular, one (Re2), two (Re1 and Re2) or three (Re1, 
Re2 and Rd1) CWD affected animals’ samples were not detected at 10−5, 10−6 or 10−7 dilutions, respectively 
(Fig. 3b). Notably, this substrate hardly detected Norwegian reindeer CWD prions compared to the moose and 
red deer ones. The reaction was stopped at 53 hours and none of the negative controls induced unspecific reaction. 
We analyzed whether the prion protein sequence homology between CWD prions and substrate could increase 
the power of discrimination between prion affected and healthy animals. We then analyzed the samples using PrP 
substrates with amino acid sequences of deer, reindeer and elk. Surprisingly, while deer PrP (Fig. 3c) was still able 
to detect CWD affected animals’ samples with sensitivity and specificity quite comparable to that of Syrian ham-
ster PrP, reindeer (Fig. 3d) and elk PrP (Fig. 3e) were characterized by a very rapid aggregation in both the pos-
itive and the negative samples. Even with a time threshold of 3 hours, we could not clearly discriminate between 
CWD affected animals and healthy controls. Thus, PrP substrates with cervid sequences appear to be less efficient 
in detecting CWD prions than those with bank vole and Syrian hamster sequences.
Two brain samples from CWD affected white-tailed deer (WTd) from North America were included in the 
RT-QuIC analysis to verify whether the overall performance of the assay could have been influenced by the origin 
of the CWD prions (Norway vs North America). The two isolates were provided to the Norwegian Veterinary 
Institute in Oslo in 2006 as part of a ring trial (courtesy of Aru Balachandran, Canadian Food Inspection Agency, 
Alberta, Canada). In this case, their seeding activities were similar to that of Norwegian CWD affected deer, in 
terms of lag phase and fluorescence intensity (Fig. 4 and see Supplementary Fig. S1).






Mo1 CWD Lierne Female 13 + −
Mo2 CWD Selbu Female 13 + −
Mo3 CWD Selbu Female 14 + −
Mo4 Healthy Råde Unknown >1 − −
Mo5 Healthy Voss Male >1 − −
Cervus elaphus
Rd1 CWD Gjemnes Female 16 + −
Rd2 Healthy Eid Female >1 − −
Rd3 Healthy Årdal Male >1 − −
Rangifer tarandus 
tarandus
Re1 CWD Nordfjella Male >1 + +
Re2 CWD Nordfjella Female >1 + +
Re3 CWD Nordfjella Male >1 + +
Re4 CWD Nordfjella Female >1 − +
Re5 CWD Nordfjella Male 1.5 − +
Re6 CWD Nordfjella Female >1 − +
Re7 CWD Nordfjella Male 8 − +
Re8 Healthy Lom Male >1 − −
Re9 Healthy Lom Female >1 − −
Table 2. Demographic information and TeSeETM WB results of the Norwegian animals included in this study.
Figure 1. TeSeETM WB results of brain and lymph nodes collected from the healthy (black) and CWD affected 
(red) animals included in the study. (a) PrPres was detected in all brain homogenates of CWD affected moose 
(Mo1, Mo2, Mo3), red deer (Rd1) and 3 brain homogenates (out of 7) of CWD affected reindeer. Notably, no 
PrPres was detected in the brains of CWD affected reindeer 4, 5, 6, and 7; (b) PrPres was however detected in 
the lymph nodes of all the CWD affected reindeer. PrPres was not found in brain and lymph nodes of healthy 
animals. Numbers on the left of the Western blots indicate molecular weights (kDa).
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RT-QuIC analysis with bank vole PrP enables efficient prion detection in reindeer brain samples 
where PrPSc was not biochemically detected. Finally, we have analyzed samples collected from CWD 
affected reindeer (Re4, Re5, Re6, Re7) where PrPSc had only been detected in the lymph nodes and not the brain 
with TeSeETM ELISA and WB. We decided not to perform serial dilutions given the lack of WB signal in the brain 
samples and chose a dilution of 10−5. As previously observed, the bank vole PrP was the most efficient at detecting 
prions in all the CWD affected reindeer (Fig. 5a). The Syrian hamster PrP did not detect 2 out of 4 CWD samples 
(Re6 and Re7) (Fig. 5b); whilst deer (Fig. 5c) and reindeer PrP (Fig. 5d) did not detect 3 out of the 4 CWD samples 
(Re4, Re6, Re7 and Re4, Re5, Re6, respectively). Elk PrP did not detect any of them (Fig. 5e).
Discussion
First discovered in deer in Colorado many decades ago, CWD rapidly spread to many other American states98 and 
Canada10. In April 2016, the disease was diagnosed in a Norwegian reindeer from the Nordfjella area3. This was 
the first case of CWD in Europe, and the first reindeer reported with naturally occurring CWD. This disease is 
contagious within cervid populations and can efficiently transmit directly between animals or through the envi-
ronment. Healthy animals can be infected after close contact with saliva, urine and feces of affected ones (direct 
horizontal transmission) or after being exposed to environments contaminated with excreta or carcasses of dis-
eased animals (indirect horizontal transmission). Prions persist in the environment for long time and contribute 
significantly to disease spreading.
In Europe surveillance programs are aimed at detecting the presence of CWD in wild and farmed cervids. 
The validated and approved diagnostic tests require animals to be sacrificed for sampling the CNS (e.g. brain-
stem) and/or lymphoid tissue for ELISA, WB and IHC based analyses61. Although these tests reach high levels of 
diagnostic accuracy for CWD, PrPSc accumulation in brain and lymphoid tissues can be lower than the detection 
threshold of the tests, especially in the early stages of disease. In addition, different CWD prion strains can affect 
test performance, as in the case of Nor98/atypical scrapie99.
In this work we evaluated the efficiency of the highly sensitive RT-QuIC assay in detecting low amounts of 
CWD prion in different Norwegian cervid species. Our aim was to set up optimal conditions for PrPSc detection, 
regardless of prion strains and animal species. For this reason, brain homogenates of CWD affected moose, red 
deer and reindeer were serially diluted and subjected to RT-QuIC analysis performed using Syrian hamster, bank 
vole, deer, reindeer and elk PrP as reaction’s substrates.
Our results indicated that the bank vole PrP enabled CWD prion detection in every brain dilution of all cervid 
species, especially in reindeer where PrPSc detection was more challenging compared to the other species and 
we could clearly discriminate CWD affected animals from healthy controls. A slightly less efficient detection of 
CWD prions was observed using Syrian hamster PrP. By using bank vole PrP we could detect prions in brain 
samples of reindeer that had tested negative with traditional diagnostic tests. Moreover, we efficiently detected 
PrPSc in samples from North American cervids, which have CWD prion strains that might be different from those 
found in Norway9. Thus, the use of bank vole PrP overcomes strain-related effects which are known to influence 
the efficiency of the RT-QuIC. The capability of bank vole PrP to detect a wide range of prion strains has already 
been reported100 and here we demonstrate for the first time that this substrate enables high efficient detection of 
multiple CWD strains in different Norwegian CWD affected cervids.
Efficient transmission of TSE infection requires a close similarity between the primary amino acid sequence 
of the PrP in the donor and in the recipient animal. This allows PrPSc to interact specifically with and convert the 
host’s PrPC into the disease-associate isoform and could explain why CWD is so easily transmissible between 
different cervid species26,101,102. Our results showed that the efficiency of the RT-QuIC test was reduced by the 
use of deer PrP, especially in reindeer, and the sensitivity dropped drastically when using reindeer and elk PrP. 
Nevertheless, similar observations have been made in the field of human prion diseases: the use of human PrP 
substrate for RT-QuIC analyses results in lower sensitivity and specificity compared to Syrian hamster or bank 
vole PrP for detecting PrPSc in peripheral tissues (e.g. cerebrospinal fluid and olfactory mucosa) of prion diseased 
patients103–107.
Figure 2. Amino acid sequences of recombinant PrP proteins used for RT-QuIC experiments. The amino acid 
sequence of deer PrP was used as reference for aligning the sequences of reindeer, elk, Syrian hamster and bank 
vole PrP. Arrows and rectangles indicate beta-sheets (β1 and β2) and alpha helix (α1, α2 and α3) secondary 
structures, respectively.
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PrP sequences of other species, including human and non-cervid ruminants, are dissimilar to that of cervids 
and this limits the efficiency of interspecies CWD transmission. Nevertheless, the potential risk of interspecies 
transmission of CWD represents a serious public health concern since humans, cattle and sheep could be exposed 
to CWD prions through the consumption of prion-infected feed or from contact with a prion-contaminated 
Figure 3. RT-QuIC results of CWD affected animals with detectable PrPSc in the brain. RT-QuIC analysis of 
serial brain homogenate dilutions (from 10−5 to 10−7) from CWD affected animals and controls with (a) bank 
vole, (b) Syrian hamster, (c) deer, (d) reindeer and (e) elk recombinant truncated PrP. Each sample was analyzed 
in triplicate and black dots indicate the time taken for each replicate to reach the fluorescence threshold (lag 
phase). The vertical line indicates the time threshold set up for each PrP substrate. Rd: red deer, Mo: moose; Re: 
reindeer. Mean value and standard error of the mean (S.E.M) are shown.
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environment. It is estimated that more than 60% of Americans have eaten deer or elk meat or their derived 
products108 while a large number of cattle, sheep and goats have grazed in CWD contaminated environments. 
Thankfully, controlled natural exposure studies and targeted surveillance programs currently indicate no cases of 
natural interspecies transmission of CWD10,109–113.
Experimentally, CWD can efficiently be transmitted by intracerebral inoculation in mice, mink, squirrel mon-
keys, ferrets, sheep and some cattle10,109,114–118. But attempts to transmit to transgenic mice overexpressing human 
prion protein119 or to Cynomologus macaques120, which are evolutionarily closer to humans, were unsuccessful. 
This suggests little or no zoonotic potential. The efficiency of CWD transmission to humans has been also eval-
uated in vitro with highly sensitive PMCA and RT-QuIC techniques. Some studies showed that the human PrP 
can be converted to the pathologic form by CWD prions. It was suggested that the efficiency of this conversion 
is highly influenced by (i) human PrP polymorphism (recipient), (ii) cervid PrP polymorphism (donor) and 
(iii) isolates origin (strain)121–125. Overall, experiments performed using in vitro amplification techniques suggest 
that the species barrier between cervids and human is not absolute. However, although these techniques mimic 
in vitro the process of prion conversion, they lack many of the biological interactions occurring in vivo and the 
results, regarding the study of the complex phenomenon of the species barrier, should be carefully interpreted. 
In addition, the species barrier does not only depend on the PrP sequence homology between host and recipient, 
but also the prion strain. It is therefore conceivable that different CWD strains may have different abilities at 
crossing the species barrier. Many other factors may play a pivotal role in driving this phenomenon. CWD prions 
can undergo to processes of selection and adaptation once the interspecies transmission has occurred, with the 
generation of new prion conformers more prone to propagate in the new host and likely easier to transmit within 
the species126,127. For instance, prions from cattle affected by bovine spongiform encephalopathy (BSE) crossed 
the species barrier (although with low efficiency) and infected humans, generating a new disease named variant 
Creutzfeldt-Jakob disease (vCJD)128. There is therefore considerable concern that CWD prions could cross the 
species barrier, adapt to humans and result in new forms of prion disease. The ongoing surveillance has not 
reported any documented cases of CWD transmission to humans at present. However, the lack of interspecies 
transmission cannot definitively be ruled out112,129.
Our optimized RT-QuIC performed with bank vole PrP could be used as first step screening assay followed by 
traditional confirmatory TeSeE ELISA, WB or IHC assays to increase the accuracy of CWD detection in affected 
animals. After a process of validation where many more samples of CWD affected animals and negative controls 
will be analyzed with this technique, it could be employed as new tool for the diagnosis of CWD either at clinical 
or preclinical stage of the disease. In addition, considering its elevated analytical sensitivity and rapidity, RT-QuIC 
might also be exploited for a quick and efficient PrPSc detection in tissues and biological fluids, such as urine, 
saliva or feces. These samples are easier to collect than CNS and lymphoid tissues and do not require immobiliza-
tion or euthanasia of animals. This test could also be used to confirm the absence of infection in animals prior to 
restocking. Finally, other than monitoring the spreading of CWD prions between cervid species, RT-QuIC with 
bank vole PrP can be further extended to evaluate the presence of prions in tissues collected from other animals 
(e.g. sheep, goats, cattle) eventually exposed to contaminated environment.
In conclusion, we provide evidence that RT-QuIC performed with bank vole PrP as reaction substrate is 
capable of detecting CWD prions, regardless of the cervid species, strains and geographical origin, with good 
analytical sensitivity and specificity. This rapid and useful technique is, in combination with traditional diagnostic 
tests, ideal for screening samples containing low concentrations of CWD prions.
Figure 4. RT-QuIC results of CWD affected Norwegian and North American cervid species. Brain 
homogenates were diluted at 10−5 and/or 10−6 and analyzed by RT-QuIC using bank vole and Syrian hamster 
recombinant truncated PrP. Each sample was analyzed in triplicate and black dots indicate the time taken for 
each replicate to reach the fluorescence threshold (lag phase). The vertical line indicates the time threshold 
set up for each PrP substrate. WTd: white tailed deer (North America); Rd: red deer; Mo: moose; Re: reindeer. 
Mean value and standard error of the mean (S.E.M) are shown.
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Materials and Methods
Compliance with Ethical Standards. All animal samples included in this study were provided by the 
Norwegian surveillance program for CWD in compliance with ethical standards.
Animals. The following animals from Norway were included in the study: (i) 5 Moose (Alces alces) (3 affected 
by CWD and 2 healthy animals), (ii) 3 red deer (Cervus elaphus) (1 affected by CWD and 2 healthy animals) and 
(iii) 9 reindeer (Rangifer tarandus tarandus) (7 affected by CWD and 2 healthy animals). The information con-
cerning the animal’s geographical origin, sex, age and diagnostic status is summarized in Table 2.
teSeetM ELISA and WB tests for CWD diagnosis. All the CWD affected animals were first detected by 
the Norwegian surveillance program for CWD, using commercially available tests for the detection of PrPSc. Brain 
tissues and a piece of lymph node were homogenized at 20% (weight/volume) in individual grinding tubes. Rapid 
test TeSeETM SAP ELISA (Bio-Rad) was carried out according to the manufacturer’s instruction. Positive ELISA 
samples were then analyzed with TeSeETM Western blot (Bio-Rad) for confirmation.
teSeetM Western blot analysis of brain and lymph nodes samples. The homogenates submitted to 
Western blot were collected from the grinding tubes primarily analyzed by rapid test TeSeE™ ELISA. The WB 
test was performed, with slight modifications, according to the manufacturer’s instructions. Briefly, PrPC was 
Figure 5. RT-QuIC results of CWD affected reindeer where PrPSc was not biochemically detected in the brain. 
Brain homogenates were diluted at 10−5 and analyzed by RT-QuIC using (a) bank vole, (b) Syrian hamster, (c) 
deer, (d) reindeer and (e) elk recombinant truncated PrP. Each sample was analyzed in triplicate and black dots 
indicate the time to reach the fluorescence threshold (lag-phase) of each replicate. The vertical line indicates the 
time threshold set up for each PrP substrate. Rd: red deer; Mo: moose; Re: reindeer. Mean value and standard 
error of the mean (S.E.M) are shown.
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digested by incubating the homogenates with Proteinase K (20 µl per ml) for 10 min at 37 °C. Electrophoresis 
was performed using mini-PROTEAN® TGX™ Precast Gels (Bio-Rad) and Power Pac Universal (first 10 min at 
60 V followed by approximately 35 min at 120 V). Gels were then electroblotted using semi-dry transfer apparatus 
(Trans-Blot® Turbo™ Transfer System, Bio-Rad) onto polyvinylidene fluoride (PVDF) membrane (Bio-Rad). The 
immunoblotting process began by blocking the membrane, to prevent unspecific bindings, with the kit’s block 
solution for 30 min, then a second 30 min incubation was carried out using monoclonal antibodies SHa31 (AbI 
from the kit) and an additional monoclonal antibody (P4) at a dilution of 1:1000. Lastly, a 20 min incubation with 
goat anti-mouse immunoglobulin G (IgG) antibody conjugated with horseradish peroxidase (AbII from the kit) 
was carried out. The test’s chemiluminescent substrate ECL (Western blotting detecting reagents, Amersham 
ECLTM) was then added and the chemiluminescent signals were visualized using ChemiDoc System (Bio-Rad). 
The samples were declared positive if characteristic banding patterns of PK-resistant core of PrPSc were present.
RT-QuIC recombinant substrates production. Truncated Syrian hamster (90–231), reindeer (94–234; 
176D), deer (94–234; 96 G), elk (94–234; 132 M) and bank vole PrP (90–231; 109 M) constructs were purchased 
from GenScript. The constructs were expressed in Escherichia coli BL21 (DE3) cells (Stratagene). Freshly 
transformed overnight culture was inoculated into Luria Bertani (LB) medium and 100 μg/mL ampicillin. At 
0.8 OD600 expression was induced with isopropyl b-D galactopyranoside (IPTG) to a final concentration of 
0.75 mM. Cells were grown in a BioStat-B plus fermentor (Sartorius). The cells were lysed by a homogenizer 
(PandaPLUS 2000) and the inclusion bodies were suspended in buffer containing 25 mM Tris-HCl, 5 mM EDTA, 
0.8% TritonX100, pH 8, and then in bi-distilled water several times. Inclusion bodies containing recombinant 
proteins were dissolved in 5 volumes of 8 M guanidine hydrochloride (GndHCl), loaded onto pre-equilibrated 
HiLoad 26/60 Superdex 200-pg column, and eluted in 25 mM Tris–HCl (pH 8), 5 mM ethylenediaminetetraacetic 
acid (EDTA), and 6 M GndHCl at a flow/rate of 2 mL/min. Proteins refolding was performed by dialysis against 
refolding buffer (20 mM sodium acetate and 0.005% NaN3 (pH 5.5)) using a Spectrapor membrane. Purified 
proteins were analyzed by SDS-polyacrylamide gel electrophoresis under reducing conditions and Western blot. 
Aliquots of the recombinant proteins were stored at −80 °C in 10 mM phosphate buffer (pH 5.8).
Preparation of the samples for RT-QuIC analyses. Brain tissues were homogenized at 10% (weight/
volume) in Bio Rad buffer (from TeSeETM grinding tubes), serially diluted (from 10−5 to 10−7) and subjected to 
RT-QuIC analysis. Two brain tissues of CWD affected white tailed deer (WTd) collected from North America 
(used for a ring trial for CWD diagnosis in 2006) were homogenized, diluted at 10−5 and 10−6 and included in 
the analysis.
RT-QuIC experimental procedures. Protein substrate solutions were allowed to thaw at room temper-
ature and filtered through a 100 kDa Nanosep centrifugal device (Pall Corporation). Samples were analyzed in 
triplicate in a black 96-well optical flat bottom plate (ThermoScientific). The final reaction volume was 100 µL and 
the reagents (Sigma) were concentrated as follow: 150 mM NaCl, 0.002% SDS, 10 mM PBS, 1 mM EDTA, 10 µM 
ThT and 0.13 mg/ml of recPrP. To avoid contamination, reaction mixes were prepared and loaded (98 µL) onto the 
microplate in a prion-free laboratory. After the addition of 2 µL of diluted brain homogenates (from 10−5 to 10−7), 
the plate was sealed with a sealing film (ThermoScientific) and inserted into a FLUOstar OPTIMA microplate 
reader (BMG Labtech). The plate was incubated at 55 °C with cycles of 1 min shaking (at 600 rpm, double orbital) 
and 1 min incubation. Fluorescence readings (480 nm) were taken every 15 min (30 flashes per well at 450 nm). 
A sample was considered positive if the two highest fluorescence values (AU) of the replicates were greater than 
10.000 AU and at least two, out of three replicates, crossed the time threshold that was set for each recombinant 
substrate. We set the following time thresholds for each PrP: (i) Syrian hamster 48 hours, (ii) bank vole 10 hours, 
(iii) deer 3.5 hours, (iv) reindeer 3 hours and (v) elk 3 hours. In particular, we have evaluated the time at which the 
unspecific aggregation of each PrP template occurred in the presence of negative samples (analyzed at least three 
different times). We have then set this value as time-threshold. Therefore, all samples able to promote PrP aggre-
gation before this time-threshold were considered able to exert a seeding activity while the others were considered 
unable to promote a seeding activity for each PrP substrate. Data are plotted in graphs showing the time taken for 
each replicate (black dots) to reach the fluorescence threshold (lag phase).
Statistical analyses and graphic representation. Statistical analysis (mean and standard error of 
the mean (S.E.M.)) and graphic representations of our data were performed using the Prism software (v5.0 
GraphPad).
Data availability
All data generated or analyzed during this study are included in this published article.
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